Gastric Cancer Prevention: Evaluating U.S. Risk Factor Trends and New Technology

胃癌预防:评估美国危险因素趋势和新技术

基本信息

  • 批准号:
    8298248
  • 负责人:
  • 金额:
    $ 15.17万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-09-01 至 2015-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The goal of the proposed research is to identify effective gastric cancer prevention programs that improve cancer outcomes, reduce disparities, and enhance the cost-effectiveness of gastric cancer prevention in the U.S. This will be accomplished by constructing a flexible decision-analytic simulation model of gastric cancer capable of estimating the contribution of risk factor patterns on gastric cancer trends and assessing the costs, benefits, and cost-effectiveness of primary (smoking cessation) and secondary (surveillance) prevention strategies. As several factors are changing the landscape of gastric cancer control, including a better understanding of the disease natural history, role of risk factors on disease progression, and new noninvasive endoscopic technology to detect and treat precancerous and cancerous lesions, this model will synthesize available clinical, epidemiologic, and economic data to project long-term outcomes and guide clinical study design. Our specific aims are: (1) to develop a natural history model of gastric cancer, including the role of risk factors on disease progression. This model will be empirically calibrated using U.S. epidemiologic data on age-specific prevalence and incidence of precancerous lesions and cancer; (2) to estimate the decline in gastric cancer incidence attributable to declining prevalence of H. pylori, smoking, and other risk factors. Using a population-based model of gastric cancer we will incorporate data on risk factor trends to forecast gastric cancer incidence and mortality; (3) to assess the cost-effectiveness of technology-based surveillance and treatment strategies for patients with precancerous lesions. We will evaluate the effectiveness of endoscopic and serology-based diagnostic and therapeutic technologies for dysplastic and asymptomatic cancerous lesions; (4) to compare the relative effectiveness of alternative gastric cancer control strategies on disparities. We will develop natural history models for specific race/ethnicity, immigrant, and other select subgroups, incorporate demographic trends, and assess the impact of prevention and treatment strategies to improve cancer outcomes and reduce disparities. In summary, this research will synthesize the best available data, improve upon an existing modeling framework, and develop a new set of analytic tools to estimate and project gastric cancer trends; establish management guidelines for patients with gastric precancerous lesions; and provide insight on the relative costs, benefits, and risks associated with different gastric cancer prevention and control strategies. My career goal is to become an independent investigator dedicated to the application of multidisciplinary, decision- analytic methods to improve cancer prevention and control policies. In conjunction with additional training in secondary data analysis, advanced decision-analytic methods, and epidemiology, the execution of this proposed mentored research in a multidisciplinary and highly-collaborative environment will provide the additional experience, knowledge, and skills needed to successfully transition to research independence.
描述(由申请人提供):拟议研究的目标是确定有效的胃癌预防计划,以改善癌症结果、减少差异并提高美国胃癌预防的成本效益。这将通过构建一个灵活的计划来实现胃癌决策分析模拟模型,能够估计危险因素模式对胃癌趋势的贡献,并评估一级(戒烟)和二级(监测)预防的成本、收益和成本效益策略。由于多个因素正在改变胃癌控制的前景,包括更好地了解疾病自然史、危险因素对疾病进展的作用以及检测和治疗癌前病变和癌性病变的新无创内窥镜技术,该模型将综合现有的临床数据、流行病学和经济数据来预测长期结果并指导临床研究设计。我们的具体目标是:(1)开发胃癌的自然史模型,包括危险因素对疾病进展的作用。该模型将使用美国关于癌前病变和癌症特定年龄患病率和发病率的流行病学数据进行经验校准; (2) 估计幽门螺杆菌患病率下降、吸烟和其他危险因素导致的胃癌发病率下降。使用基于人群的胃癌模型,我们将结合危险因素趋势数据来预测胃癌的发病率和死亡率; (3) 评估针对癌前病变患者基于技术的监测和治疗策略的成本效益。我们将评估内窥镜和基于血清学的诊断和治疗技术对发育异常和无症状癌性病变的有效性; (4) 比较不同胃癌控制策略的相对有效性差异。我们将为特定种族/民族、移民和其他选定亚群体开发自然历史模型,纳入人口趋势,并评估预防和治疗策略对改善癌症结果和减少差异的影响。总之,这项研究将综合现有的最佳数据,改进现有的建模框架,并开发一套新的分析工具来估计和预测胃癌趋势;制定胃癌前病变患者的管理指南;并提供与不同胃癌预防和控制策略相关的相对成本、收益和风险的见解。我的职业目标是成为一名独立研究者,致力于应用多学科决策分析方法来改进癌症预防和控制政策。结合二次数据分析、高级决策分析方法和流行病学方面的额外培训,在多学科和高度协作的环境中执行这项拟议的指导研究将提供成功过渡到研究所需的额外经验、知识和技能独立。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jennifer M. Yeh其他文献

Identification of novel MAP kinase pathway signaling targets by functional proteomics and mass spectrometry.
通过功能蛋白质组学和质谱鉴定新的 MAP 激酶途径信号传导靶点。
  • DOI:
    10.1016/s1097-2765(00)00132-5
  • 发表时间:
    2000-12-01
  • 期刊:
  • 影响因子:
    16
  • 作者:
    Timothy S. Lewis;J. Hunt;Lauren D. Aveline;K. Jonscher;Donna F. Louie;Jennifer M. Yeh;T. Nahreini;K. Resing;N. Ahn;N. Ahn
  • 通讯作者:
    N. Ahn

Jennifer M. Yeh的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jennifer M. Yeh', 18)}}的其他基金

Can risk-reducing medications improve breast cancer prevention in childhood and adolescent cancer survivors? Comparative modeling to inform care
降低风险的药物可以改善儿童和青少年癌症幸存者的乳腺癌预防吗?
  • 批准号:
    10459788
  • 财政年份:
    2022
  • 资助金额:
    $ 15.17万
  • 项目类别:
Can risk-reducing medications improve breast cancer prevention in childhood and adolescent cancer survivors? Comparative modeling to inform care
降低风险的药物可以改善儿童和青少年癌症幸存者的乳腺癌预防吗?
  • 批准号:
    10675772
  • 财政年份:
    2022
  • 资助金额:
    $ 15.17万
  • 项目类别:
Genetic testing to guide pediatric cancer care and follow up: using anthracycline-associated cardiac toxicity as a model for the future
基因检测指导儿科癌症护理和随访:使用蒽环类药物相关的心脏毒性作为未来的模型
  • 批准号:
    9789024
  • 财政年份:
    2018
  • 资助金额:
    $ 15.17万
  • 项目类别:
Genetic testing to guide pediatric cancer care and follow up: using anthracycline-associated cardiac toxicity as a model for the future
基因检测指导儿科癌症护理和随访:使用蒽环类药物相关的心脏毒性作为未来的模型
  • 批准号:
    10231094
  • 财政年份:
    2018
  • 资助金额:
    $ 15.17万
  • 项目类别:
Gastric Cancer Prevention: Evaluating U.S. Risk Factor Trends and New Technology
胃癌预防:评估美国危险因素趋势和新技术
  • 批准号:
    8133736
  • 财政年份:
    2010
  • 资助金额:
    $ 15.17万
  • 项目类别:
Gastric Cancer Prevention: Evaluating U.S. Risk Factor Trends and New Technology
胃癌预防:评估美国危险因素趋势和新技术
  • 批准号:
    8522167
  • 财政年份:
    2010
  • 资助金额:
    $ 15.17万
  • 项目类别:
Gastric Cancer Prevention: Evaluating U.S. Risk Factor Trends and New Technology
胃癌预防:评估美国危险因素趋势和新技术
  • 批准号:
    7989369
  • 财政年份:
    2010
  • 资助金额:
    $ 15.17万
  • 项目类别:
Gastric Cancer Prevention: Evaluating U.S. Risk Factor Trends and New Technology
胃癌预防:评估美国危险因素趋势和新技术
  • 批准号:
    8706073
  • 财政年份:
    2010
  • 资助金额:
    $ 15.17万
  • 项目类别:

相似海外基金

Sensitivity of toddler screening: Integrating concurrent and prospective strategies to detect ASD
幼儿筛查的敏感性:整合同步和前瞻性策略来检测 ASD
  • 批准号:
    10680190
  • 财政年份:
    2023
  • 资助金额:
    $ 15.17万
  • 项目类别:
Clonal hematopoiesis and inherited genetic variation in sickle cell disease
镰状细胞病的克隆造血和遗传变异
  • 批准号:
    10638404
  • 财政年份:
    2023
  • 资助金额:
    $ 15.17万
  • 项目类别:
The Health of Aging Parents of Adult Children with Serious Conditions
患有严重疾病的成年子女的年迈父母的健康
  • 批准号:
    10660046
  • 财政年份:
    2023
  • 资助金额:
    $ 15.17万
  • 项目类别:
Optimizing Transitions for Dual-Use Veterans Living with Dementia followingHospitalization in the Community
优化社区住院后患有痴呆症的两用退伍军人的过渡
  • 批准号:
    10538945
  • 财政年份:
    2023
  • 资助金额:
    $ 15.17万
  • 项目类别:
Harnessing Network Science to Personalize Scalable Interventions for Adolescent Depression
利用网络科学对青少年抑郁症进行个性化的可扩展干预措施
  • 批准号:
    10786569
  • 财政年份:
    2023
  • 资助金额:
    $ 15.17万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了